Influenza A virus infections induce a variety of pro-and antiviral-acting signaling processes (12, 13) . Very recently the phosphatidylinositol 3-kinase (PI3K) and its downstream effector Akt/protein kinase B have been added to the list of influenza A virus-induced signaling mediators (5, 9, 18) . PI3K is involved in a wide variety of cellular events, generating lipid signals downstream of receptors and influencing diverse cellular pathways (20, 21) . In the context of an influenza A virus infection, PI3K was identified as a perfect example of a seemingly antiviral signaling component that is misused by the virus to support its replication. While on one hand the kinase regulates virus-and double-stranded RNA (dsRNA)-induced IRF-3 activation (5, 17) , on the other hand PI3K activity is hijacked by the virus to support effective virus uptake in early stages as well as preventing apoptosis late in infection (5, 6) . It was a striking finding of several laboratories that the nonstructural protein 1 (NS1) of influenza A viruses (A/NS1) induces PI3K activation at advanced stages of the replication cycle (6, 9, 10, 18, 23) . Previously, the A/NS1 protein had been known only as a suppressor of signaling events, blocking dsRNAdependent enzymes (7) and/or interfering with the RNA sensor RIG-I (14-16). These activities lead to suppression of signaling pathways and activation of transcription factors, e.g., of NF-B or IRF-3 (11) .
Despite the fact that the NS1 protein of influenza B virus (B/NS1) possesses less than 20% amino acid sequence identity to A/NS1, both proteins fulfill similar but not identical functions. B/NS1 acts as an interferon antagonist (2, 7, 19) and inhibits the interferon-inducible protein kinase R (3); however, B/NS1, in contrast to A/NS1, is not able to inhibit polyadenylation, splicing, and nuclear export of cellular mRNA (22) . Consequently, the question was raised whether PI3K activation is induced upon influenza B virus infection to the same extent as upon influenza A virus infection and whether B/NS1 acts similarly to A/NS1 to promote PI3K activity and suppress premature apoptosis induction. Fig. 1A and B, left) . Additionally, a much stronger Akt phosphorylation was detected 4 h to 8 h after infection ( Fig. 1A and B, left) , concomitant with and likely to be caused by A/NS1 expression (6) . In influenza B virus-infected cells an early and transient phase of Akt phosphorylation was observed starting from 15 min up to 2 h p.i. (Fig. 1A and B, middle and right). However, in clear contrast to the findings with influenza A viruses, type B virusinfected cells did not show any Akt phosphorylation at 4 h or 8 h p.i., even though B/NS1 is highly expressed. In addition, we directly compared the potentials to activate PI3K during infections with influenza B/Lee/40 virus, the PR8 strain, and the avian influenza A virus strain A/FPV/Bratislava/79 (FPV). MDCK cells were infected for 4 h and 8 h, and lysates were analyzed for Akt phosphorylation as well as A/NS1 and B/NS1 expression. Consistent with the earlier results, we observed again a strong correlation between A/NS1 expression and Akt phosphorylation (Fig. 1C) . There was hardly any Akt phosphorylation detectable at 4 h p.i. in FPV-infected cells, which correlated well with a low expression level of the A/NS1 protein at this time point. However, when A/NS1 concentrations had accumulated at 8 h p.i., phosphorylated Akt was easily detected. In PR8-infected cells, A/NS1 expression was already detectable at 4 h p.i., which correlated with an early Akt phosphorylation at this time point. In contrast, influenza B virusinfected cells showed an abundant B/NS1 protein expression at 4 h and 8 h p.i. that increased with time without any induction of Akt phosphorylation. Taken together, these data indicate that B/NS1 protein expression does not correlate with induction of PI3K/Akt signaling at the selected time points during viral replication.
Influenza B virus protein NS1 does not induce PI3K/Akt signaling. To evaluate the PI3K-activating potential of A/NS1 and B/NS1 when they are expressed as single proteins, A549 cells were transfected with an empty vector (Fig. 1D, lane 1) or plasmids expressing myc-tagged A/NS1 (Fig. 1D, lane 2) or B/NS1 proteins (Fig. 1D, lane 3) . PI3K-dependent phosphorylation of Akt was observed only in the presence of A/NS1, while B/NS1 expression failed to activate Akt, although equal levels of the two proteins were expressed (Fig. 1D) . Similar results were also obtained when employing constructs expressing A/NS1 and B/NS1 without a tag (data not shown).
Requirement for PI3K activity is restricted to very early stages of the infection cycle of influenza B viruses.
A remaining question concerns a potential function of PI3K activation early during influenza B virus infection. Recently we have shown that PI3K plays an important role during influenza A virus entry processes and that the early inhibition of PI3K activity results in decreased virus propagation (5) . Since the PI3K/Akt pathway is activated very early upon infection with influenza B viruses and its activity is even more pronounced than that in influenza A virus-infected cells (Fig. 1A of progeny virus reduced (Fig. 2) . While in influenza A virusinfected cells PI3K inhibition led to a pronounced effect on progeny virus titers for up to 2 h p.i. (Fig. 2B) (5) , no significant effects were observed in influenza B virus-infected cells if the inhibitor was added later than 30 min p.i. Similar results were obtained using another PI3K inhibitor, LY294002 (50 M) (data not shown). This indicates that PI3K activity is required for efficient growth of influenza A viruses at both early and intermediate stages of the replication cycle, while in influenza B virus-infected cells the requirement for PI3K activity is restricted to very early stages.
The B/NS1 protein does not function in the antiapoptotic effect of PI3K activity. The recent finding that A/NS1-induced PI3K activity at later stages of influenza A virus infection suppresses premature apoptosis induction (6) leads to the assumption that in influenza B virus infections, where the late PI3K activation is missing, this activity is not required. To examine this hypothesis, A549 cells were infected with previously described recombinant influenza A and B viruses expressing either wild-type NS1 proteins (PR8, 230 amino acids, or B/Lee, 281 amino acids) or C-terminally truncated mutant derivatives thereof carrying little more than the dsRNA-binding domain (A/NS1-125 and B/NS1-104) (3, 5) (Fig. 3A) . In addition we infected cells with mutant virus strains bearing full deletions of the protein (⌬A/NS1 or ⌬B/NS1) (2, 8) (Fig. 3B) . At 8 h p.i. phosphorylation of Akt was strongly induced in PR8-infected cells expressing wild-type A/NS1, but not upon infection with the mutants. Conversely, in cells infected with the mutant viruses a strong onset of apoptotic caspase activity was observed as measured by cleavage of poly(ADP-ribose) polymerase (PARP), a prominent substrate of caspases (Fig.  3A and B) . This indicates that full-length A/NS1 protein is required to suppress apoptosis. Infection with influenza B/Lee/40 virus led to only a marginal induction of PI3K/Akt activation, while infection with the B/NS1-104 or the ⌬B/NS1 virus mutant did not induce Akt phosphorylation. Interestingly, neither wild-type nor mutant influenza B virus infection led to PARP cleavage within the time frame analyzed. From these findings one can speculate that influenza B viruses may have developed a mechanism to avoid or suppress apoptosis induction that is independent of B/NS1. Furthermore, one could also argue that there is a much earlier onset of apoptosis in influenza A virus-infected cells that needs suppression by A/NS1 via induction of PI3K activity. Influenza B viruses might induce apoptosis to a lesser extent or in a delayed fashion and would not require an apoptosis-suppressing function in the stage of replication at which B/NS1 is expressed. With regard to the activation mechanism, it is interesting that the tyrosine at position 89 of A-type viruses that has been shown to be 
